Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Toll-Like Receptors Gene Polymorphisms in Autoimmune Disease. | Front Immunol | 2021 | 33981318 | PubTator, text mining | PubMed |
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation. | Haematologica | 2021 | 33979991 | PubTator, text mining | PubMed |
| MyD88 TIR domain higher-order assembly interactions revealed by microcrystal electron diffraction and serial femtosecond crystallography. | Nat Commun | 2021 | 33972532 | PubTator, text mining | PubMed |
| A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19. | J Biomed Inform | 2021 | 33965637 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Hepatitis C Virus Relapse After Ultrashort Direct-Acting Antiviral Therapy Associates With Expression of Genes Involved With Natural Killer-Cell and CD8+ T-Cell Function. | Open Forum Infect Dis | 2021 | 33959672 | PubTator, text mining | PubMed |
| MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling. | J Cell Biol | 2021 | 33956941 | PubTator, text mining | PubMed |
| Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19. | Front Immunol | 2021 | 33936053 | PubTator, text mining | PubMed |
| T Cell-Mediated Immune Responses to AAV and AAV Vectors. | Front Immunol | 2021 | 33927727 | PubTator, text mining | PubMed |
| Dipterocarpus tuberculatus Roxb. Ethanol Extract Has Anti-Inflammatory and Hepatoprotective Effects In Vitro and In Vivo by Targeting the IRAK1/AP-1 Pathway. | Molecules | 2021 | 33926126 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Antiphospholipid Syndrome: State-of-the-Art and Future Challenges. | Int J Mol Sci | 2021 | 33925261 | PubTator, text mining | PubMed |
| Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients. | Cells | 2021 | 33923537 | PubTator, text mining | PubMed |
| From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy. | Molecules | 2021 | 33920054 | PubTator, text mining | PubMed |
| Probiogenomics of Lactobacillus delbrueckii subsp. lactis CIDCA 133: In Silico, In Vitro, and In Vivo Approaches. | Microorganisms | 2021 | 33919849 | PubTator, text mining | PubMed |
| Type I Interferon Production of Plasmacytoid Dendritic Cells under Control. | Int J Mol Sci | 2021 | 33919546 | PubTator, text mining | PubMed |
| IL-1R1 deficiency impairs liver regeneration after 2/3 partial hepatectomy in aged mice. | Turk J Biol | 2021 | 33907503 | PubTator, text mining | PubMed |
| Interferon lambda in inflammation and autoimmune rheumatic diseases. | Nat Rev Rheumatol | 2021 | 33907323 | PubTator, text mining | PubMed |
| Evaluation of E. coli Nissle1917 derived metabolites in modulating key mediator genes of the TLR signaling pathway. | BMC Res Notes | 2021 | 33902702 | PubTator, text mining | PubMed |
| There's more to death than life: Noncatalytic functions in kinase and pseudokinase signaling. | J Biol Chem | 2021 | 33895136 | PubTator, text mining | PubMed |
| Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease. | Arthritis Res Ther | 2021 | 33892792 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=64